3 edition of Pyxis found in the catalog.
Source title: Pyxis (The Discovery)(Pyxis Series)
|LC Classifications||Oct 02, 2011|
|The Physical Object|
|Pagination||xvi, 75 p. :|
|Number of Pages||95|
nodata File Size: 1MB.
We are developing next-generation ADCs using both novel and validated linker-payload combinations and site-specific conjugation techniques derived from the proprietary Flexible Pyxis Conjugation Technology FACT ADC Platform. Before BCG, he worked in corporate development at Gilead Sciences and market planning at Genentech.
Prior to joining Arix he was for four years CEO of Rigontec GmbH, a German Biotech start-up company in the immune oncology space. Fibronectin is a glycoprotein Pyxis in the extracellular matrix.
Prior to this, Steve served as Senior Vice President Pyxis Development at Aura Biosciences where he spearheaded all product technical development efforts for their Virus-Like drug conjugate AU-011. in Medicine at the Imperial College of London. Before joining Pyxis, Christian was Senior Vice President, European Operations of Coley Pharmaceutical Group, Inc, a pioneer in the development of immunostimulatory oligonucleotides, and served as Managing Director of Coley GmbH.
in Business Administration from Marquette University and his M. joined Pyxis in July 2021 as the Chief Financial Officer with responsibility for finance, legal and human resources. He is also the Founder and CEO of Portal Innovations, a life sciences venture development engine.
from University of Notre Dame in the Department of Chemical Engineering and graduated summa cum laude. From March 2012 to November 2013, she served as Vice President of Business Operations at Salesforce, Pyxis from March 2002 to April 2010, Ms. from the University of Chicago Booth School of Business and holds a B. in biology from Cornell University. Steve Monks Chief Technical Officer Steve is the Chief Technical Officer at Pyxis Oncology.
Before entering Pyxis life science industry Christian was successfully performing academic research at the Max Planck Institute in Martinsried, Germany.
Ronald has co -authored more than 100 publications and is co-inventor on 17 pending or granted patents.
Ronald conducted his postdoctoral research in the Department of Biology at Stanford University.
in Business Administration from Marquette University and his M.